MoneyWorks4Me

A fair growth of 16.02% in the revenue at Rs. 2079.30 millions was reported in the September 2024 quarter as compared to Rs. 1792.20 millions during year-ago period.A good growth in profit of 28.79% reported to Rs. 1057.40  millions over Rs. 821.00 millions of corresponding previous quarter.Operating profit for the quarter ended September 2024 rose to 1411.70 millions as compared to 1139.40 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2079.30 1792.20 16.02 3935.70 3528.80 11.53 6250.90 5286.10 18.25
Other Income 430.10 244.90 75.62 645.10 517.60 24.63 1058.40 990.00 6.91
PBIDT 1411.70 1139.40 23.90 2440.50 2178.30 12.04 3929.20 3189.20 23.20
Interest 0.20 0.20 0.00 0.40 0.50 -20.00 1.00 1.20 -16.67
PBDT 1411.50 1139.20 23.90 2440.10 2177.80 12.04 3928.20 3188.00 23.22
Depreciation 64.90 67.20 -3.42 126.70 133.90 -5.38 270.80 256.50 5.58
PBT 1346.60 1072.00 25.62 2313.40 2043.90 13.19 3657.40 2931.50 24.76
TAX 289.20 251.00 15.22 530.60 460.20 15.30 820.30 588.90 39.29
Deferred Tax -2.30 -19.90 -88.44 -6.60 -29.70 -77.78 -40.90 -76.90 -46.81
PAT 1057.40 821.00 28.79 1782.80 1583.70 12.57 2837.10 2342.60 21.11
Equity 152.00 151.90 0.07 152.00 151.90 0.07 151.90 151.80 0.07
PBIDTM(%) 67.89 63.58 6.79 62.01 61.73 0.45 62.86 60.33 4.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..